POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RA

被引：0
|
作者：
Walker, David [1 ]
Winthrop, Kevin [2 ]
Genovese, Mark C. [3 ]
Combe, Bernard G. [4 ]
Tanaka, Yoshiya [5 ]
Kivitiz, Alan [6 ]
Matzkies, Franziska [7 ]
Bartok, Beatrix [7 ]
Ye, Lie [8 ]
Guo, Ying [8 ]
Tasset, Chantal [9 ]
Sundy, John S. [7 ]
Keystone, Edward [10 ,11 ]
Westhovens, Rene [12 ]
Rigby, William [13 ]
Burmester, Gerd R. [14 ]
机构：
[1] Northumbria Healthcare NHS Fdn Trust, Rheumatol, Newcastle Upon Tyne, Tyne & Wear, England
[2] Oregon Hlth & Sci Univ, Ophthalmol, Portland, OR 97201 USA
[3] Stanford Univ, Immunol & Rheumatol, Palo Alto, CA 94304 USA
[4] Montpellier Univ, CHU Montpellier, Rheumatol, Montpellier, France
[5] Univ Occupat & Environm Hlth, Rheumatol, Kitakyushu, Fukuoka, Japan
[6] Altoona Ctr Clin Res, Rheumatol, Altoona, PA USA
[7] Gilead Sci, Rheumatol, Foster City, CA USA
[8] Gilead Sci, Biostat, Foster City, CA USA
[9] Galapagos NV, Rheumatol, Mechelen, Belgium
[10] Mt Sinai Hosp, Rheumatol, Toronto, ON, Canada
[11] Univ Toronto, Toronto, ON, Canada
[12] Univ Hosp Leuven, Rheumatol, Leuven, Belgium
[13] Dartmouth Coll, Rheumatol, 1 Med Ctr Dr, Lebanon, NH 03756 USA
[14] Charite Univ Med Berlin, Rheumatol, Berlin, Germany
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O09
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies
    Roeth, Alexander
    Fu, Rong
    He, Guangsheng
    Alzahrani, Hazzaa
    Chou, Sheng-Chieh
    Hicheri, Yosr
    Kazmierczak, Maciej
    Recova, Viviane Lacorte
    Uchiyama, Michihiro
    Vladareanu, Ana-Maria
    Beveridge, Leigh
    Buatois, Simon
    Buri, Muriel
    Compagno, Nicolo
    Shi, Dayu
    Balachandran, Nadiesh
    Sreckovic, Sasha
    Scheinberg, Phillip
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (02) : 373 - 382
  • [42] Long-Term Weight and Metabolic Effects of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies
    Newcomer, John W.
    Jiang, Ying
    DiPetrillo, Lauren
    Yagoda, Sergey
    Yu, Bei
    Bhupathi, Vasudev
    McDonnell, David
    Graham, Christine
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S242 - S242
  • [43] Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies
    Marder, Stephen
    Fleischhacker, W. Wolfgang
    Earley, Willie
    Lu, Kaifeng
    Zhong, Yan
    Nemeth, Gyorgy
    Laszlovszky, Istvan
    Szalai, Erzsebet
    Durgam, Suresh
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (01) : 127 - 136
  • [44] Safety and tolerability of tegaserod in patients with chronic constipation: Pooled data from two phase III studies
    Quigley, Eamonn M. M.
    Wald, Arnold
    Fidelholtz, James
    Boivin, Michel
    Pecher, Eckhard
    Earnest, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (05) : 605 - 613
  • [45] Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies
    Kenji Miki
    Makoto Ohta
    Manabu Abe
    Hiroki Yoshimatsu
    Koichi Fujii
    Nozomi Ebata
    Christine R. West
    Mark T. Brown
    Glenn Pixton
    Naoki Isogawa
    Pain and Therapy, 2022, 11 : 827 - 844
  • [46] Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies
    Miki, Kenji
    Ohta, Makoto
    Abe, Manabu
    Yoshimatsu, Hiroki
    Fujii, Koichi
    Ebata, Nozomi
    West, Christine R.
    Brown, Mark T.
    Pixton, Glenn
    Isogawa, Naoki
    PAIN AND THERAPY, 2022, 11 (03) : 827 - 844
  • [47] First-dose effects of fingolimod: Pooled safety data from three phase 3 studies
    DiMarco, John P.
    O'Connor, Paul
    Cohen, Jeffrey A.
    Reder, Anthony T.
    Zhang-Auberson, Lixin
    Tang, Dejun
    Collins, William
    Kappos, Ludwig
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (05) : 629 - 638
  • [48] Overview of fremanezumab pooled safety data from placebo-controlled phase 2 and 3 studies
    Silberstein, Stephen D.
    Faulhaber, Nicola
    Ning, Xiaoping
    Yeung, Paul P.
    Schiemann, Jimmy
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [49] Overview of Fremanezumab Pooled Safety Data from Placebo-Controlled Phase 2 and 3 Studies
    Silberstein, S. D.
    Faulhaber, N.
    Ning, X.
    Yeung, P. P.
    Schiemann, J.
    Yang, R.
    Ma, Y.
    Aycardi, E.
    HEADACHE, 2018, 58 : 174 - 174
  • [50] Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies
    Trang, Michael
    Seroogy, Julie D.
    Van Wart, Scott A.
    Bhavnani, Sujata M.
    Kim, Aryun
    Gibbons, Jacqueline A.
    Ambrose, Paul G.
    Rubino, Christopher M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
12345